BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26454000)

  • 1. The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.
    Mach J; Huizer-Pajkos A; Mitchell SJ; McKenzie C; Phillips L; Kane A; Jones B; de Cabo R; Cogger V; Le Couteur DG; Hilmer SN
    Fundam Clin Pharmacol; 2016 Feb; 30(1):23-34. PubMed ID: 26454000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits.
    Sarich TC; Youssefi M; Zhou T; Adams SP; Wall RA; Wright JM
    Arch Toxicol; 1996; 70(12):835-40. PubMed ID: 8911642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by
    Ruan LY; Fan JT; Hong W; Zhao H; Li MH; Jiang L; Fu YH; Xing YX; Chen C; Wang JS
    Toxicol Lett; 2018 Oct; 295():256-269. PubMed ID: 29936297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
    Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
    Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity mechanisms of isoniazid: A mini-review.
    Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
    J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
    Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
    Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation in murine hepatotoxicity to the antituberculosis agent «Isoniazide».
    Souayed N; Chennoufi M; Boughattas F; Haouas Z; Maaroufi K; Miled A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
    Chronobiol Int; 2015; 32(9):1201-10. PubMed ID: 26479844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of aging on acetaminophen pharmacokinetics, toxicity and Nrf2 in Fischer 344 rats.
    Mach J; Huizer-Pajkos A; Cogger VC; McKenzie C; Le Couteur DG; Jones BE; de Cabo R; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):387-97. PubMed ID: 23863315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CYP3A in isoniazid metabolism in vivo.
    Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X
    Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles.
    Bhandari R; Kaur IP
    Int J Pharm; 2013 Jan; 441(1-2):202-12. PubMed ID: 23220081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
    Zhou L; Song Y; Zhao J; Qin H; Zhang G; Zhou Y; Wu X
    Pharm Biol; 2016; 54(6):931-7. PubMed ID: 26987268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of isoniazid: The good, the bad, and the alternatives.
    Erwin ER; Addison AP; John SF; Olaleye OA; Rosell RC
    Tuberculosis (Edinb); 2019 May; 116S():S66-S70. PubMed ID: 31076322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients.
    Santos NP; Callegari-Jacques SM; Ribeiro Dos Santos AK; Silva CA; Vallinoto AC; Fernandes DC; de Carvalho DC; Santos SE; Hutz MH
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):499-504. PubMed ID: 23394127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of cytochrome p450 2E1 promoter induced by low dosage of isoniazid.
    Shen L; Zhang B; Sun S; Feng F
    Environ Toxicol Pharmacol; 2013 Jul; 36(1):149-51. PubMed ID: 23619520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxygen free radicals in isoniazid-induced hepatotoxicity.
    Walubo A; Smith P; Folb PI
    Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):649-55. PubMed ID: 9922980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats.
    Yue J; Peng RX; Yang J; Kong R; Liu J
    Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in the rat livers induced by low dosage isoniazid treatment.
    Zhang B; Sun S; Shen L; Zu X; Chen Y; Hao J; Huang X; Feng F
    Environ Toxicol Pharmacol; 2011 Nov; 32(3):486-90. PubMed ID: 22004970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor.
    Sarich TC; Adams SP; Petricca G; Wright JM
    J Pharmacol Exp Ther; 1999 May; 289(2):695-702. PubMed ID: 10215642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of isoniazid-induced hepatotoxicity.
    Perwitasari DA; Atthobari J; Wilffert B
    Drug Metab Rev; 2015 May; 47(2):222-8. PubMed ID: 26095714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of Asparagus racemosus on oxidative damage in isoniazid-induced hepatotoxic rats: an in vivo study.
    Palanisamy N; Manian S
    Toxicol Ind Health; 2012 Apr; 28(3):238-44. PubMed ID: 21724661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.